Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

FLUX attributes changed

  • Technical Exchange News
  • Aug. 01, 2026, 06:33 UTC
  • 4
  • 0 comments

FLUX attributes changed: Attr: Fin_status N -> D;

Comment Full text

UPL LIMITED (BYS)

  • Business News
  • Aug. 01, 2026, 05:57 UTC
  • 3
  • 1 comments

General Announcement: Update regarding Composite Scheme of Arrangement

Market reaction Comment Full text

BITDEER TECHNOLOGIES GROUP (BTDR)

  • Business News
  • Aug. 01, 2026, 04:30 UTC
  • 3
  • 1 comments

Bitdeer Announces Second Quarter 2026 Earnings Conference Call for August 10th 2026

Market reaction Comment Full text

NIO INC. (NIO)

  • Business News
  • Aug. 01, 2026, 04:16 UTC
  • 3
  • 1 comments

General Announcement: NIO Inc. Provides July 2026 Delivery Update

Market reaction Comment Full text

NIO INC. (NIO)

  • Business News
  • Aug. 01, 2026, 04:15 UTC
  • 3
  • 1 comments

NIO Inc. Provides July 2026 Delivery Update

Market reaction Comment Full text

URANIUM ENERGY CORP (UEC)

  • SEC News
  • Aug. 01, 2026, 03:33 UTC
  • 4
  • 0 comments

New Form 4/A - URANIUM ENERGY CORP <b>Filed:</b> 2026-07-31 <b>AccNo:</b> 0001437749-26-025287 <b>Size:</b> 28 KB

Comment Full text

WISE GROUP PLC (WSE)

  • Business News
  • Aug. 01, 2026, 02:50 UTC
  • 1
  • 1 comments

Investor Alert: Robbins LLP Informs Investors of the Wise Group plc Class Action Lawsuit

Market reaction Comment Full text

PROCEPT BIOROBOTICS CORP (PRCT)

  • Business News
  • Aug. 01, 2026, 02:00 UTC
  • 0
  • 1 comments

PROCEPT BioRobotics Corporation Securities Fraud Class Action Result of Undisclosed Inventory Issues and approximately 18% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

Market reaction Comment Full text

ERASCA, INC. (ERAS)

  • Business News
  • Aug. 01, 2026, 02:00 UTC
  • 0
  • 1 comments

Erasca, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

Market reaction Comment Full text

VIA TRANSPORTATION, INC. (VIA)

  • Business News
  • Aug. 01, 2026, 02:00 UTC
  • 0
  • 1 comments

Via Transportation, Inc. Securities Class Action Result of Undisclosed Growth Obstacles and approximately 70% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

Market reaction Comment Full text

FUTU HOLDINGS LTD (FUTU)

  • Business News
  • Aug. 01, 2026, 02:00 UTC
  • 0
  • 1 comments

Futu Holdings Limited Securities Fraud Class Action Result of Undisclosed Regulatory Compliance Failures and approximately 32% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

Market reaction Comment Full text

LI AUTO INC. (LI)

  • Business News
  • Aug. 01, 2026, 02:00 UTC
  • 0
  • 1 comments

Li Auto Inc. July 2026 Delivery Update

Market reaction Comment Full text

EQUIPMENTSHARE.COM INC (EQPT)

  • Business News
  • Aug. 01, 2026, 02:00 UTC
  • 0
  • 1 comments

EquipmentShare.com Inc. Notice of September 21, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

Market reaction Comment Full text

WIX.COM LTD. (WIX)

  • Business News
  • Aug. 01, 2026, 02:00 UTC
  • 0
  • 1 comments

Wix.com Ltd. Notice of September 22, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

Market reaction Comment Full text

ADMA BIOLOGICS, INC. (ADMA)

  • Business News
  • Aug. 01, 2026, 02:00 UTC
  • 0
  • 1 comments

ADMA Biologics, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

Market reaction Comment Full text
  • Previous
  • 1
  • 2
  • 3
  • 4
  • Next

Search

News categories

  • Technical Exchange News(14037)
  • Event(6229)
  • SEC News(358189)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(216752)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin